Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04117477 · ClinicalTrials.gov registry record · Phase 2
Xylitol - Healthcare Associated Infection Reduction in Stem Cell Transplant Patients
A Phase 2 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Terminated
- Registry status
- Phase 2
- Development phase
- 46
- Enrollment target
NCT04117477 is a Phase 2 study that was terminated before completion, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 46 participants.
The verdict
NCT04117477, a Phase 2 study, was terminated before completion, sponsored by Children's Hospital Medical Center, Cincinnati.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 46 participants
- Enrollment target
Study Summary
The central hypothesis is that daily dental xylitol wipes, in addition to current oral care practice, are effective at reducing BSI from oral organisms, and decreasing the incidence of gingivitis, oral plaque, and oral ulcerations after SCT.
Interventions
- OTHER Placebo
- DRUG Xylitol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2019-09-27 |
| Est. Completion | 2021-03-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04117477
The ClinicalTrials.gov registry entry for NCT04117477 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04117477 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04117477 about?
NCT04117477 is a clinical study titled "Xylitol - Healthcare Associated Infection Reduction in Stem Cell Transplant Patients". The central hypothesis is that daily dental xylitol wipes, in addition to current oral care practice, are effective at reducing BSI from oral organisms, and decreasing the incidence of gingivitis, oral plaque, and oral ulcerations after SCT.
What is the current status of trial NCT04117477?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 46 participants. The study started on 2019-09-27. Estimated completion is 2021-03-20.
What interventions are being tested in trial NCT04117477?
The interventions under investigation include: Placebo (OTHER), Xylitol (DRUG).
Who is sponsoring clinical trial NCT04117477?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.